当前位置:首页 - 行情中心 - 微芯生物(688321) - 财务分析

微芯生物

(688321)

  

流通市值:94.80亿  总市值:94.80亿
流通股本:4.11亿   总股本:4.11亿

微芯生物(688321)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-0.18亿元,每股收益-0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益168945.01万元,未分配利润9927.72万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产321347.55万元,负债152402.54万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入130,604,180.46523,710,192.86348,588,993.34241,603,895.8
营业总成本148,782,922.18719,282,373.12534,287,482.27384,048,599.6
营业利润-17,665,088.4897,071,775.7114,533,476.42160,541,516.13
利润总额-17,119,342.0897,018,888.54113,917,851.32160,521,752.07
净利润-18,304,645.5349,187,509.0968,432,323.32116,038,712.19
其他综合收益112,699.581,068,982.281,941,210.12,382,654.95
综合收益总额-18,191,945.9550,256,491.3770,373,533.42118,421,367.14
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计1,104,076,109.711,130,086,854.541,092,223,550.881,136,672,124.4
非流动资产合计2,109,399,387.152,073,162,574.582,062,000,289.682,024,480,854.62
资产总计3,213,475,496.863,203,249,429.123,154,223,840.563,161,152,979.02
流动负债合计352,429,362.15390,805,456.29351,429,393.49369,501,104.12
非流动负债合计1,171,596,043.151,102,548,100.881,070,862,055.61,011,671,649.71
负债合计1,524,025,405.31,493,353,557.171,422,291,449.091,381,172,753.83
归属于母公司股东权益合计1,689,450,091.561,709,895,871.951,731,932,391.471,779,980,225.19
股东权益合计1,689,450,091.561,709,895,871.951,731,932,391.471,779,980,225.19
负债和股东权益合计3,213,475,496.863,203,249,429.123,154,223,840.563,161,152,979.02
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计214,740,201.48519,262,417.25390,534,387.87249,162,145.72
经营活动现金流出小计179,312,011.31676,536,051.6502,547,542.19370,541,841.75
经营活动产生的现金流量净额35,428,190.17-157,273,634.35-112,013,154.32-121,379,696.03
投资活动现金流入小计467,099,064.261,170,754,939.89750,839,196.43498,386,791.08
投资活动现金流出小计441,629,595.571,545,760,725.331,135,517,773.31714,618,586.9
投资活动产生的现金流量净额25,469,468.69-375,005,785.44-384,678,576.88-216,231,795.82
筹资活动现金流入小计81,100,000623,094,528.43544,264,528.43479,164,528.43
筹资活动现金流出小计47,686,258.86240,477,124.46205,213,458.73167,352,625.76
筹资活动产生的现金流量净额33,413,741.14382,617,403.97339,051,069.7311,811,902.67
汇率变动对现金及现金等价物的影响163,689.341,083,290.991,997,965.333,449,712.09
现金及现金等价物净增加额94,475,089.34-148,578,724.83-155,642,696.17-22,349,877.09
期末现金及现金等价物余额361,164,427.9266,689,338.56259,625,367.22392,918,186.3
最新报告期:2024-04-19
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
海通证券余文心,朱赵明-0.39-0.190.032024-04-19
TOP↑